Q2 2020 Holdings
Filed 2020-08-14 | 114 holdings | $6.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $2.2B | 11,777,285 | 35.0% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $2.0B | 41,904,586 | 32.0% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $936.1M | 7,589,294 | 14.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $501.4M | 3,390,270 | 7.9% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $229.6M | 1,019,557 | 3.6% |
| Cerus Corporation(CERS) | COM | 157085101 | $90.5M | 13,713,195 | 1.4% |
| Axsome Therapeutics, Inc.(AXSM) | COM | 05464T104 | $83.1M | 1,009,757 | 1.3% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $66.8M | 6,675,181 | 1.1% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $65.6M | 13,766,405 | 1.0% |
| Aurinia Pharmaceuticals Inc.(AUPH) | COM | 05156V102 | $27.7M | 1,701,929 | 0.4% |
| Altimmune, Inc.(ALT) | COM | 02155H200 | $22.6M | 2,107,600 | 0.4% |
| Adaptive Biotechnologies Corporation(ADPT) | COM | 00650F109 | $22.4M | 463,539 | 0.4% |
| Seattle Genetics, Inc. | COM | 812578102 | $8.0M | 47,269,424 | 0.1% |
| Autolus Therapeutics plc(AUTL) | SPON ADS | 05280R100 | $7.8M | 485,624 | 0.1% |
| Cabaletta Bio, Inc.(CABA) | COM | 12674W109 | $7.1M | 636,363 | 0.1% |
| Alector, Inc.(ALEC) | COM | 014442107 | $6.8M | 280,000 | 0.1% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $5.6M | 317,857 | 0.1% |
| Incyte Corporation(INCY) | COM | 45337C102 | $3.3M | 31,999,081 | 0.1% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $3.0M | 121,534 | 0.0% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $2.3M | 500,000 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $983.3K | 8,760,794 | 0.0% |
| Kodiak Sciences Inc.(KOD) | COM | 50015M109 | $626.4K | 11,574,538 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $359.0K | 11,850,962 | 0.0% |
| MyoKardia, Inc. | COM | 62857M105 | $305.7K | 3,164,234 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR | 023111206 | $238.7K | 34,496,685 | 0.0% |
| IGM Biosciences, Inc.(1K0) | COM | 449585108 | $229.5K | 3,144,223 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $169.8K | 1,499,212 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $161.0K | 1,409,784 | 0.0% |
| Exact Sciences Corporation(EXAS) | COM | 30063P105 | $160.5K | 1,846,139 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $110.7K | 906,986 | 0.0% |
| Principia Biopharma Inc.(PRNB) | COM | 74257L108 | $94.5K | 1,580,873 | 0.0% |
| Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | $93.0K | 2,000,000 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $88.5K | 6,018,104 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $83.3K | 3,025,384 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $79.0K | 1,687,500 | 0.0% |
| Atreca, Inc.(BCELUSD) | CL A COM | 04965G109 | $75.2K | 3,532,760 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $71.3K | 2,799,577 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $64.2K | 14,614,264 | 0.0% |
| Zymeworks Inc. | COM | 98985W102 | $61.6K | 1,708,472 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $60.2K | 2,700,055 | 0.0% |
| Neoleukin Therapeutics, Inc. | COM | 64049K104 | $56.4K | 3,397,740 | 0.0% |
| ChemoCentryx, Inc.(CCXIEUR) | COM | 16383L106 | $54.4K | 945,221 | 0.0% |
| Allakos Inc.(ALLKGUSD) | COM | 01671P100 | $52.9K | 735,469 | 0.0% |
| Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | $51.1K | $30,770,000 | 0.0% |
| Aeglea BioTherapeutics, Inc.(AGLEUSD) | COM | 00773J103 | $40.5K | 4,379,592 | 0.0% |
| Assembly Biosciences, Inc. | COM | 045396108 | $36.0K | 1,541,618 | 0.0% |
| Krystal Biotech, Inc.(KRYS) | COM | 501147102 | $33.9K | 817,631 | 0.0% |
| Protagonist Therapeutics, Inc.(PTGX) | COM | 74366E102 | $33.8K | 1,911,446 | 0.0% |
| Merus N.V. | COM | N5749R100 | $32.8K | 2,037,469 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | COM | 03753U106 | $29.3K | 896,551 | 0.0% |